DK0533213T3 - Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasis - Google Patents
Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasisInfo
- Publication number
- DK0533213T3 DK0533213T3 DK92119073.2T DK92119073T DK0533213T3 DK 0533213 T3 DK0533213 T3 DK 0533213T3 DK 92119073 T DK92119073 T DK 92119073T DK 0533213 T3 DK0533213 T3 DK 0533213T3
- Authority
- DK
- Denmark
- Prior art keywords
- azelastine
- psoriasis
- control
- active agent
- glycerol ethers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F3/00—Dredgers; Soil-shifting machines
- E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
- E02F3/18—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels
- E02F3/20—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels
- E02F3/205—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels with a pair of digging wheels, e.g. slotting machines
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F3/00—Dredgers; Soil-shifting machines
- E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
- E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
- E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F3/00—Dredgers; Soil-shifting machines
- E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
- E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
- E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
- E02F3/92—Digging elements, e.g. suction heads
- E02F3/9212—Mechanical digging means, e.g. suction wheels, i.e. wheel with a suction inlet attached behind the wheel
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mechanical Engineering (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Mining & Mineral Resources (AREA)
- General Engineering & Computer Science (AREA)
- Structural Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Civil Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3900607 | 1989-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0533213T3 true DK0533213T3 (da) | 1994-10-17 |
Family
ID=6371863
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90100071.1T DK0378086T3 (da) | 1989-01-11 | 1990-01-03 | Anvendelse af det aktive stof azelastin til bekæmpelse af psoriasis-sygdomme |
DK92119073.2T DK0533213T3 (da) | 1989-01-11 | 1990-01-03 | Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasis |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90100071.1T DK0378086T3 (da) | 1989-01-11 | 1990-01-03 | Anvendelse af det aktive stof azelastin til bekæmpelse af psoriasis-sygdomme |
Country Status (15)
Country | Link |
---|---|
US (1) | US5110814A (fr) |
EP (2) | EP0378086B1 (fr) |
JP (1) | JP2991733B2 (fr) |
AT (2) | ATE113208T1 (fr) |
AU (1) | AU618443B2 (fr) |
CA (1) | CA2007480C (fr) |
DE (3) | DE59007288D1 (fr) |
DK (2) | DK0378086T3 (fr) |
EG (1) | EG19912A (fr) |
ES (2) | ES2061307T3 (fr) |
HK (2) | HK50595A (fr) |
IE (1) | IE65336B1 (fr) |
MC (1) | MC2078A1 (fr) |
PT (1) | PT92821B (fr) |
SG (2) | SG30593G (fr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3190441B2 (ja) * | 1992-07-20 | 2001-07-23 | エーザイ株式会社 | 塩酸アゼラスチンを含有する安定な製剤 |
NL9201438A (nl) * | 1992-08-11 | 1994-03-01 | Prospa Bv | Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen. |
CZ199593A3 (en) * | 1992-10-02 | 1994-04-13 | Asta Medica Ag | Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr) |
US5569680A (en) * | 1995-02-13 | 1996-10-29 | Trustees Of The Univ. Of Penna | Method of treating inflammatory bowel disease with tributyrin |
JP4138910B2 (ja) * | 1997-07-02 | 2008-08-27 | 帝國製薬株式会社 | 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤 |
US6984667B2 (en) * | 1998-04-08 | 2006-01-10 | Theta Biomedical Consulting And Development Co. | Synergistic proteoglycan compositions for inflammatory conditions |
DE19826517B4 (de) * | 1998-06-15 | 2006-03-23 | Baxter Healthcare S.A. | Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette |
DE10028638A1 (de) | 2000-06-09 | 2001-12-20 | Schuelke & Mayr Gmbh | Lagerstabile Zusammensetzungen von Glycerinmonoalkylethern |
EP1677766B1 (fr) * | 2003-10-31 | 2012-03-14 | Hexal AG | Preparation pharmaceutique contenant des substances actives et presentant un enrobage |
WO2005077963A1 (fr) * | 2004-01-16 | 2005-08-25 | Institut Superieur Agricole De Beauvais | DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes. |
US20070020330A1 (en) * | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
US8758816B2 (en) * | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
MX2007006233A (es) | 2004-11-24 | 2007-11-23 | Medpointe Healthcare Inc | Composiciones que comprenden azelastina y metodos de uso de la misma. |
CA2906008C (fr) | 2013-03-13 | 2019-07-09 | Flatley Discovery Lab, Llc | Composes de pyridazinone et procedes pour le traitement de fibrose kystique |
US10835584B2 (en) * | 2016-06-17 | 2020-11-17 | Nuvothera, Inc. | Systems for treating dermal inflammatory conditions |
US11318144B2 (en) | 2019-04-12 | 2022-05-03 | LA PharmaTech Inc. | Compositions and methods for treating Alzheimer's disease and Parkinson's disease |
US10639314B1 (en) | 2019-04-30 | 2020-05-05 | LA PharmaTech Inc. | Method of treating Alzheimer's disease |
US11938139B2 (en) * | 2019-04-12 | 2024-03-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders |
US10966989B2 (en) | 2019-04-12 | 2021-04-06 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders |
US11690849B2 (en) | 2019-04-12 | 2023-07-04 | LA PharmaTech Inc. | Method of treating dementia |
US11744833B2 (en) | 2019-04-12 | 2023-09-05 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of insomnia |
US11389458B2 (en) | 2019-04-12 | 2022-07-19 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating parkinson's and huntington's disease |
US11351179B1 (en) | 2021-08-05 | 2022-06-07 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of psychiatric disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3840606A (en) * | 1969-12-05 | 1974-10-08 | Oreal | Process of producing mono and polyhydroxyl ethers |
CH572914A5 (fr) * | 1971-01-22 | 1976-02-27 | Asta Werke Ag Chem Fab | |
DE3343530A1 (de) * | 1983-12-01 | 1985-06-13 | Max Planck Gesellschaft | Arzneimittel mit verbesserter penetration der gewebsmembran |
US4871733A (en) * | 1984-04-09 | 1989-10-03 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
-
1989
- 1989-12-28 US US07/458,350 patent/US5110814A/en not_active Expired - Lifetime
-
1990
- 1990-01-03 SG SG1995905121A patent/SG30593G/en unknown
- 1990-01-03 EP EP90100071A patent/EP0378086B1/fr not_active Expired - Lifetime
- 1990-01-03 AT AT90100071T patent/ATE113208T1/de not_active IP Right Cessation
- 1990-01-03 AT AT92119073T patent/ATE111735T1/de not_active IP Right Cessation
- 1990-01-03 ES ES92119073T patent/ES2061307T3/es not_active Expired - Lifetime
- 1990-01-03 DK DK90100071.1T patent/DK0378086T3/da active
- 1990-01-03 EP EP92119073A patent/EP0533213B1/fr not_active Expired - Lifetime
- 1990-01-03 DE DE59007288T patent/DE59007288D1/de not_active Expired - Lifetime
- 1990-01-03 DE DE59007531T patent/DE59007531D1/de not_active Expired - Lifetime
- 1990-01-03 ES ES90100071T patent/ES2063841T3/es not_active Expired - Lifetime
- 1990-01-03 DE DE4000070A patent/DE4000070A1/de not_active Withdrawn
- 1990-01-03 SG SG1995905105A patent/SG30591G/en unknown
- 1990-01-03 DK DK92119073.2T patent/DK0533213T3/da active
- 1990-01-04 MC MC902086A patent/MC2078A1/fr unknown
- 1990-01-08 EG EG1090A patent/EG19912A/xx active
- 1990-01-10 AU AU47862/90A patent/AU618443B2/en not_active Expired
- 1990-01-10 CA CA002007480A patent/CA2007480C/fr not_active Expired - Lifetime
- 1990-01-10 PT PT92821A patent/PT92821B/pt not_active IP Right Cessation
- 1990-01-10 IE IE9890A patent/IE65336B1/en not_active IP Right Cessation
- 1990-01-11 JP JP2002630A patent/JP2991733B2/ja not_active Expired - Lifetime
-
1995
- 1995-04-06 HK HK50595A patent/HK50595A/xx not_active IP Right Cessation
- 1995-04-06 HK HK50495A patent/HK50495A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5110814A (en) | 1992-05-05 |
AU4786290A (en) | 1990-07-19 |
MC2078A1 (fr) | 1991-01-07 |
EG19912A (en) | 1996-05-31 |
ES2061307T3 (es) | 1994-12-01 |
EP0533213A1 (fr) | 1993-03-24 |
EP0378086B1 (fr) | 1994-10-26 |
HK50595A (en) | 1995-04-13 |
EP0378086A3 (fr) | 1991-02-06 |
DE59007531D1 (de) | 1994-12-01 |
DK0378086T3 (da) | 1994-12-12 |
IE900098L (en) | 1990-07-11 |
ES2063841T3 (es) | 1995-01-16 |
CA2007480A1 (fr) | 1990-07-17 |
SG30593G (en) | 1995-09-18 |
JPH02288827A (ja) | 1990-11-28 |
CA2007480C (fr) | 1995-08-15 |
DE59007288D1 (de) | 1994-10-27 |
ATE113208T1 (de) | 1994-11-15 |
AU618443B2 (en) | 1991-12-19 |
PT92821A (pt) | 1990-07-31 |
ATE111735T1 (de) | 1994-10-15 |
SG30591G (en) | 1995-09-18 |
JP2991733B2 (ja) | 1999-12-20 |
EP0533213B1 (fr) | 1994-09-21 |
EP0378086A2 (fr) | 1990-07-18 |
DE4000070A1 (de) | 1990-07-12 |
IE65336B1 (en) | 1995-10-18 |
HK50495A (en) | 1995-04-13 |
PT92821B (pt) | 1995-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0533213T3 (da) | Anvendelse af det aktive middel azelastin og glycerolethere til bekæmpelse af psoriasis | |
NO157020C (no) | Analogifremgangsmte ved fremstilling av terapeutisk aktive 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-aromatiske heterocykliske carboxylater. | |
NO924433L (no) | Isoksazol-4-karboksylsyreamider og hydroksyalkyliden-cyaneddiksyreamider, legemidler inneholdende disse forbindelsene og deres anvendelse | |
DK175680A (da) | Farmaceutisk praeparat i form af en polyacrylatfilm og fremgangsmaade til dets fremstilling | |
NO151362C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive urinstoffderivater. | |
NO166862C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinderivater og deres salter, solvater, hydrater og estere. | |
DK217585A (da) | Farmaceutisk middel til behandling af neoplastiske sygdomstilstande | |
NO924045L (no) | Anti-inflammatoriske hydroksamsyrer og n-hydroksyurinstoffer | |
DK71387A (da) | Terapeutisk middel til behandling af psoriasis | |
DK10488D0 (da) | Benzen-derivater med antiinflammatorisk virkning og fremgangsmaade til fremstilling deraf | |
DK164699C (da) | Analogifremgangsmaade til fremstilling af terapeutisk aktive aminopropanolderivater og fysiologisk acceptable syreadditionssalte heraf | |
DK627289D0 (da) | Anvendelse af bicyclononanderivater | |
ITMI920608A1 (it) | Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare | |
IT1110051B (it) | Procedimento per la fabbricazione di tubi sottili e laminatoio obliquo per la realizzazione del procedimento | |
DK162736C (da) | Farmaceutiske og veterinaere midler til behandling af iskaemiske hjertelidelser | |
DK632388A (da) | Pharmaceutisk middel til behandling af hyperlipidaemi hol pattedyr | |
ES258139Y (es) | Perfil perfeccionado para bridas o montantes de sujeccion u otras estructuras. | |
DK149890C (da) | Analogifremgangsmaade til fremstilling af n-(4-phenyl-2-thiazolyl)-oxamidsyre-2-ethoxyethylester | |
DK484784A (da) | Hidtil ukendte 2-tolylmorpholinderivater, der er nyttige som farmaceutiske midler | |
IT7819623A0 (it) | Composizione adatta alla purificazione del sangue e suoi impieghi. | |
NO153848C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(arylthioalkyl)-n[-(aminoalkyl)-ureaderivater. | |
DK69784D0 (da) | Pharmaceutisk komposition til behandling af psoriasis og beslaegtede lidelser | |
IT7826464A0 (it) | Derivati di n-(b-alcossi-etil)-n-(4beta fenossi -benzil)-dicloroacetamide e procedimento per la loro preparazione. | |
IT1055702B (it) | Procedimento per la fabbricazione di lastre doppie di calcestruzzo e dispositivo per l'esecuzione del procedimento | |
DK520277A (da) | Fremgangsmaade til fremstilling af et natamycinholdigt,farmaceutisk middel til anvendelse ved bekaempelse af ringorminfektioner og andre svampeinfektioner |